Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cyclophosphamide-induced pneumonitis].

F Borchsenius, A Naalsund

    Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
    |March 30, 1989
    PubMed
    Summary

    Cyclophosphamide, an alkylating agent, can cause toxic side effects like cystitis and pneumonitis. Early recognition and stopping therapy are crucial for patients with Wegener's granulomatosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bronchial wheezing predicts inflammation and respiratory failure in fire smoke victims.

    Acta anaesthesiologica Scandinavica·2017
    Same author

    The obstructive siblings: Relapsing polychondritis without chondritis?

    Respiratory medicine case reports·2015
    Same author

    High-intensity training following lung cancer surgery: a randomised controlled trial.

    Thorax·2014
    Same author

    Intrabronchial airway pressures in intubated patients during bronchoscopy under volume controlled and pressure controlled ventilation.

    Anaesthesia and intensive care·2011
    Same author

    [Acute respiratory failure caused by myotonic dystrophy].

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2001
    Same author

    [Bronchial resections].

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1997

    Area of Science:

    • Oncology
    • Immunology
    • Toxicology

    Background:

    • Cyclophosphamide is a widely used alkylating agent for cancer treatment.
    • Its immunosuppressive properties are utilized in organ transplantation and autoimmune diseases.
    • Cyclophosphamide can cause toxic side effects, potentially linked to its metabolites.

    Observation:

    • A patient undergoing treatment for Wegener's granulomatosis developed adverse effects.
    • The patient experienced cyclophosphamide-induced cystitis and pneumonitis.

    Findings:

    • Cyclophosphamide therapy was associated with the development of cystitis and pneumonitis.
    • These toxic effects highlight the importance of monitoring patients on cyclophosphamide.

    Implications:

    • Early identification and cessation of cyclophosphamide are vital for positive patient outcomes.
    • This case underscores the need for vigilance regarding cyclophosphamide's potential toxicity in patients with autoimmune conditions.
    • Further research into cyclophosphamide metabolites and their role in adverse events is warranted.

    Related Experiment Videos